Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Filings indexed 1,664 across all filing types
Latest filing 2023-11-20 Share Issue/Capital Cha…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - AVR 8 pages 30.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by Anteris Technologies Ltd. It includes information about the number and type of securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. The document references previous announcements such as Appendix 3B related to securities issuance. There is no financial performance data, management discussion, or audit information. The document is an official announcement related to the quotation (listing) of securities on the ASX, which aligns with announcements about share issues or capital changes. Therefore, this document fits the category of Share Issue/Capital Change (SHA). The document length is 7328 characters, which is substantive and contains detailed information about the securities quotation, not just a brief notice or a report publication announcement.
2023-11-20 English
Change in substantial holding 4 pages 2.0MB
Regulatory Filings
2023-11-06 English
Application for quotation of securities - AVR 8 pages 30.8KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by Anteris Technologies Ltd. It includes information about the number and type of securities to be quoted, issue dates, and distribution schedules. The document references a previous Appendix 3B announcement related to the securities issuance. There is no financial performance data, management discussion, or audit information. The document is an official announcement related to the listing or quotation of securities on the ASX, which corresponds to a capital or financing update rather than a full financial report or other categories. The document length is 7206 characters, which is sufficient to contain substantive information about the securities quotation. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-11-02 English
Cleansing Notice 2 pages 235.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 3 November 2023 regarding the issuance of new fully paid ordinary shares by Anteris Technologies Ltd. It provides details about the share issue, including the number of shares issued, the issue price, and compliance with relevant sections of the Corporations Act 2001. The document is short (3740 characters) and serves as a formal notice under section 708A(5)(e) of the Corporations Act, which is a cleansing notice related to the share issuance. There are no financial statements, management discussion, or detailed financial data present. This type of announcement fits the category of a Capital/Financing Update, as it relates to company fundraising and capital structure changes. It is not a full report, earnings release, or regulatory filing of another type.
2023-11-02 English
Change in substantial holding 4 pages 246.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power, relevant interests, and associations of a substantial shareholder in a company. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2023-11-02 English
Notification of cessation of securities - AVR 5 pages 26.3KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for Anteris Technologies Ltd. It provides specific information about the securities that have ceased, including ASX security codes, descriptions, numbers, reasons for cessation, and dates. The document is a formal announcement about changes in the company's issued capital due to securities lapsing. It does not contain financial statements, management discussion, or detailed financial data. It is not an annual or interim report, earnings release, or audit report. It is also not a regulatory certification or legal proceeding. The content fits best with a Regulatory Filing (RNS) as it is a general regulatory announcement about securities cessation that does not fit into more specific categories like capital changes (SHA) or director dealings (DIRS). The document length (5986 characters) and detailed content confirm it is a substantive announcement rather than a brief report publication announcement (RPA). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-10-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.